多重耐药和交叉耐药现象严重。
Multiple drug-resistance and cross-resistance are very serious.
临床试验表明，TPT与顺铂和紫杉醇无交叉耐药性。
Clinical non cross resistance had been demonstrated between TPT and cisplatin or paclitaxel.
头孢克肟抗菌谱广、半衰期长、交叉耐药性小、用药剂量小、适应症广泛。
Cefixime is characterized by broad spectrum, long half life period, less cross resistance to chemical reagent, small use dosage and wide scope of application.
MRSA对环丙沙星的耐药率高达79 4% ，且对其他氟喹诺酮交叉耐药。
The resistance rate of MRSA to ciprofloxacin was 79.4% and cross resistance existed.
耐替米考星的S6和BG44T菌株对红霉素、泰乐菌素、林可霉素有交叉耐药性。
Tilmicosin-resistant S6 and BG44T showed cross-resistance to erythromycin, tylosin and lincomycin.
但人型枝原体、解脲脲原体的喹诺酮类药物耐药株对YH16、YH17也存在交叉耐药性。
However, there were cross resistance YH16 and YH17 for Uu and Mh strains resistant to other quinolones.
淋球菌交叉耐药情况较为严重，79.2 %菌株对青霉素和环丙沙星呈现交叉耐药，84.2 %菌株对四环素和环丙沙星呈现交叉耐药。
The cross-resistant isolates were prevalent, 79.2% were cross-resistant to penicillin and ciprofloxacin and 84.2% to tetracycline and ciprofloxacin.
淋球菌交叉耐药情况较为严重，79.2 %菌株对青霉素和环丙沙星呈现交叉耐药，84.2 %菌株对四环素和环丙沙星呈现交叉耐药。
The cross-resistant isolates were prevalent, 79.2% were cross-resistant to penicillin and ciprofloxacin and 84.2% to tetracycline and ciprofloxacin.
应用推荐